{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:12:52Z","timestamp":1790903572077,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00198-021-06054-7","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T21:02:31Z","timestamp":1625605351000},"page":"2587-2592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hypercalcemia in non-Hodgkin\u2019s lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D"],"prefix":"10.1007","volume":"32","author":[{"given":"A.R.","family":"Gonciulea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.D.","family":"Bikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Sellmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"issue":"4","key":"6054_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart AF (2005 Jan 27) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352(4):373\u2013379","journal-title":"N Engl J Med"},{"issue":"7","key":"6054_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","volume":"112","author":"SH Ralston","year":"1990","unstructured":"Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT (1990 Apr 1) Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 112(7):499\u2013504","journal-title":"Ann Intern Med"},{"issue":"5","key":"6054_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF00132979","volume":"11","author":"G Francini","year":"1993","unstructured":"Francini G, Petrioli R, Maioli E, Gonnelli S, Marsili S, Aquino A, Bruni S (1993 Sep) Hypercalcemia in breast cancer. Clin Exp Metastasis 11(5):359\u2013367","journal-title":"Clin Exp Metastasis"},{"issue":"16","key":"6054_CR4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004 Apr 15) Mechanisms of bone metastasis. N Engl J Med 350(16):1655\u20131664","journal-title":"N Engl J Med"},{"issue":"5-6","key":"6054_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/10428199809050909","volume":"29","author":"F Firkin","year":"1998","unstructured":"Firkin F, Schneider H, Grill V (1998 May) Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy. Leuk Lymphoma 29(5-6):499\u2013506","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"6054_CR6","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1359\/JBMR.050602","volume":"20","author":"MJ Horwitz","year":"2005","unstructured":"Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocana A, Bisello A et al (2005 Oct) Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J Bone Miner Res 20(10):1792\u20131803","journal-title":"J Bone Miner Res"},{"issue":"5","key":"6054_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood.V82.5.1383.1383","volume":"82","author":"JF Seymour","year":"1993","unstructured":"Seymour JF, Gagel RF (1993 Sep 1) Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood. 82(5):1383\u20131394","journal-title":"Blood."},{"issue":"1","key":"6054_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/08880010701774033","volume":"25","author":"M Hibi","year":"2008","unstructured":"Hibi M, Hara F, Tomishige H, Nishida Y, Kato T, Okumura N et al (2008 Jan-Feb) 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma. Pediatr Hematol Oncol 25(1):73\u201378","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"6054_CR9","first-page":"E84","volume":"5","author":"V Zhu","year":"2014","unstructured":"Zhu V, de Las MA, Janicek M, Hartshorn K (2014 Aug) Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D. J Gastrointest Oncol 5(4):E84\u2013E87","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"6054_CR10","first-page":"212","volume":"12","author":"PS Akai","year":"1989","unstructured":"Akai PS, Wong T, Chang-Poon V, Green F, Whitelaw WA, Hanley DA (1989 Jun) Resectable bronchogenic carcinoma presenting with hypercalcemia: tumor-associated granulomatous reaction and probable production of 1,25-dihydroxyvitamin D. Clin Invest Med 12(3):212\u2013216","journal-title":"Clin Invest Med"},{"issue":"2","key":"6054_CR11","first-page":"417","volume":"75","author":"LJ Fraher","year":"1992","unstructured":"Fraher LJ, Hodsman AB, Jonas K, Saunders D, Rose CI, Henderson JE et al (1992 Aug) A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab 75(2):417\u2013423","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6054_CR12","first-page":"1525","volume":"86","author":"MA Syed","year":"2001","unstructured":"Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocana A, Wisniewski SR, Stewart AF (2001 Apr) Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J Clin Endocrinol Metab 86(4):1525\u20131531","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6054_CR13","first-page":"607","volume":"81","author":"K Nakayama","year":"1996","unstructured":"Nakayama K, Fukumoto S, Takeda S, Takeuchi Y, Ishikawa T, Miura M, Hata K, Hane M, Tamura Y, Tanaka Y, Kitaoka M, Obara T, Ogata E, Matsumoto T (1996 Feb) Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. J Clin Endocrinol Metab 81(2):607\u2013611","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 Pt 1","key":"6054_CR14","first-page":"E297","volume":"258","author":"AT Walker","year":"1990","unstructured":"Walker AT, Stewart AF, Korn EA, Shiratori T, Mitnick MA, Carpenter TO (1990 Feb) Effect of parathyroid hormone-like peptides on 25-hydroxyvitamin D-1 alpha-hydroxylase activity in rodents. Am J Phys 258(2 Pt 1):E297\u2013E303","journal-title":"Am J Phys"},{"issue":"9","key":"6054_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM198809013190906","volume":"319","author":"AE Broadus","year":"1988","unstructured":"Broadus AE, Mangin M, Ikeda K, Insogna KL et al (1988 Sep 1) Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med 319(9):556\u2013563","journal-title":"N Engl J Med"},{"issue":"4","key":"6054_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jbmr.5650090412","volume":"9","author":"AA Budayr","year":"1994","unstructured":"Budayr AA, Zysset E, Jenzer A, Thiebaud D, Ammann P, Rizzoli R et al (1994 Apr) Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein. J Bone Miner Res 9(4):521\u2013526","journal-title":"J Bone Miner Res"},{"issue":"5","key":"6054_CR17","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1210\/endo-124-5-2057","volume":"124","author":"S Fukumoto","year":"1989","unstructured":"Fukumoto S, Matsumoto T, Yamoto H, Kawashima H, Ueyama Y, Tamaoki N et al (1989 May) Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production. Endocrinology. 124(5):2057\u20132062","journal-title":"Endocrinology."},{"issue":"9","key":"6054_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7326\/0003-4819-121-9-199411010-00001","volume":"121","author":"JF Seymour","year":"1994","unstructured":"Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F (1994 Nov 1) Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 121(9):633\u2013640","journal-title":"Ann Intern Med"},{"issue":"2","key":"6054_CR19","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.clml.2017.12.006","volume":"18","author":"RM Shallis","year":"2018","unstructured":"Shallis RM, Rome RS, Reagan JL (2018 Feb) Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review. Clin Lymphoma Myeloma Leuk 18(2):e123\u2013e129","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"6054_CR20","first-page":"1202","volume":"78","author":"M Davies","year":"1994","unstructured":"Davies M, Hayes ME, Yin JA, Berry JL, Mawer EB (1994 May) Abnormal synthesis of 1,25-dihydroxyvitamin D in patients with malignant lymphoma. J Clin Endocrinol Metab 78(5):1202\u20131207","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6054_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1359\/jbmr.2003.18.3.579","volume":"18","author":"M Hewison","year":"2003","unstructured":"Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D et al (2003 Mar) Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18(3):579\u2013582","journal-title":"J Bone Miner Res"},{"issue":"3","key":"6054_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/1097-0142(19910801)68:3<642::AID-CNCR2820680334>3.0.CO;2-A","volume":"68","author":"K Hoekman","year":"1991","unstructured":"Hoekman K, Tjandra YI, Papapoulos SE (1991 Aug 1) The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein. Cancer. 68(3):642\u2013647","journal-title":"Cancer."},{"key":"6054_CR23","doi-asserted-by":"publisher","first-page":"32,6823","DOI":"10.1186\/1472-6823-14-32","volume":"14","author":"R Rodriguez-Gutierrez","year":"2014","unstructured":"Rodriguez-Gutierrez R, Zapata-Rivera MA, Quintanilla-Flores DL, Camara-Lemarroy CR, Lavalle-Gonzalez FJ, Gonzalez-Gonzalez JG et al (2014) 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma. BMC Endocr Disord 14:32,6823\u20133214-32","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"6054_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4158\/EP.15.3.234","volume":"15","author":"SB Shivnani","year":"2009","unstructured":"Shivnani SB, Shelton JM, Richardson JA, Maalouf NM (2009 Apr) Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma. Endocr Pract 15(3):234\u2013239","journal-title":"Endocr Pract"},{"issue":"4","key":"6054_CR25","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.bone.2006.11.009","volume":"40","author":"GG Van den Eynden","year":"2007","unstructured":"Van den Eynden GG, Neyret A, Fumey G, Rizk-Rabin M, Vermeulen PB, Bouizar Z et al (2007 Apr) PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor. Bone. 40(4):1166\u20131171","journal-title":"Bone."},{"issue":"803","key":"6054_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/pgmj.68.803.753","volume":"68","author":"SR Johnston","year":"1992","unstructured":"Johnston SR, Hammond PJ (1992 Sep) Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia-lymphoma. Postgrad Med J 68(803):753\u2013755","journal-title":"Postgrad Med J"},{"key":"6054_CR27","first-page":"2475725","volume":"2020","author":"T Ogawa","year":"2020","unstructured":"Ogawa T, Miyata J, Fukunaga K, Kawana A, Inoue T (2020) Successful Treatment for Hypercalcemia due to Cosecretion of Parathyroid Hormone-Related Protein and 1,25-Dihydroxyvitamin D 3 in Non-Small-Cell Lung Cancer: A Case Report and Literature Review. Case Rep Pulmonol 2020:2475725","journal-title":"Case Rep Pulmonol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06054-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T07:05:10Z","timestamp":1637564710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6054"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06054-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}